Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant's cardiac rhythm management sales up 18%

This article was originally published in Clinica

Executive Summary

In the first results since its initial public offering last December, Guidant has reported strong sales growth of its cardiac rhythm management (CRM) products. These rose 18% in the fourth quarter compared with a year earlier. Guidant points out that operating expenses rose just 1% in the fourth quarter and CEO Ronald Dollens considers this reflects Guidant's initial success at cost control.

Topics

UsernamePublicRestriction

Register

MT090521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel